by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
IMPROVE Start and End dates: 2016 to 2020 Source of Funding: DFID/MRC/Wellcome Trust and European and Developing Countries Clinical Trials Partnership (EDCTP) ($1.8m) The overall aim of the study is to provide the WHO with definitive evidence to determine whether...
by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
IMPROVE 2 IPTp with dihydroartemisinin-piperaquine and single-course azithromycin for malaria, sexually transmitted and reproductive tract infections in HIV-infected pregnant women in Kenya and Malawi: a multi-centre, 3-arm placebo-controlled trial Start and End...
by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
REVAMP Randomized controlled trial of the effect of intravenous iron on anemia in Malawian pregnant women Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($1.6 million) An individual-randomized Phase III, open-label clinical...
by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
REVAMP Accept Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Feasibility and Acceptability Start and End dates: 2017 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($20,000) This is a...
by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
REVAMP Observe Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Observation Cohort Start and End dates: 2018 to 2022 Source of Funding: Bill & Melinda Gates Foundation ($0.75 million) This is a cohort study...
by gil5on | Jun 9, 2020 | Maternal Health & Wellbeing
REVAMP TT Randomized controlled trial of the effect of intravenous iron on anaemia in Malawian pregnant women (REVAMP): Third Trimester Start and End dates: 2020 to 2024 Source of Funding: Bill & Melinda Gates Foundation ($4.6 million) This is an open-label clinical...
Recent Comments